Normal Cognition
6
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older
Retinal Imaging in Neurodegenerative Disease
NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK
CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)
Cardiovascular Risk Factors and Cognitive Trajectories
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension